Dr. Roy Fleischmann from the University of Texas Southwestern Medical Center in Dallas, Texas, presents a study of multiple switches between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis.

The study was published in The Lancet Rheumatology in August 2023.
Read the full paper here: [ Ссылка ]00161-3/fulltext?dgcid=youtube_video_tlrheu

Visit The Lancet Rheumatology at [ Ссылка ]
Find out more at [ Ссылка ]

* * *
Continue this conversation on social! Follow us today at…
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]

свернуть